top of page

Scientific collaboration 

Patrice Forget

amouraux.jpg

Clinical chair in Anaesthesia, University of Aberdeen

Publications

2018

PDF

Pain management in living related adult donor hepatectomy: feasibility of an evidence-based protocol in 100 consecutive donors

BMC Research Notes

Dewe G, Steyaert A, De Kock M, Lois F, Reding R, Forget P.

11(1):834

2017

PDF

Bilateral tactile hypersensitivity and neuroimmune responses after spared nerve injury in mice lacking vasoactive intestinal peptide

Experimental Neurology

Gallo A, Leerink M, Michot B, Ahmed E, Forget P, Mouraux A, Hermans E.

293:62-73

2016

PDF

Feasibility of Topical Applications of Natural High-Concentration Capsaicinoid Solutions in Patients with Peripheral Neuropathic Pain: A Retrospective Analysis

Pain Research and Management

Bauchy F, Mouraux A, Deumens R, Leerink M, Ulpiano Trillig A, le Polain de Waroux B, Steyaert A, Quetin-Leclercq J, Forget P.

​

2016

PDF

A new model of nerve injury in the rat reveals a role of Regulator of G protein Signaling 4 in tactile hypersensitivity

Experimental Neurology

Taccola G, Doyen PJ, Damblon J, Dingu N, Ballarin B, Steyaert A, Rieux AD, Forget P, Hermans E, Bosier B, Deumens R.

286:1-11

2016

PDF

Does the perioperative analgesic/anesthetic regimen influence the prevalence of long-term chronic pain after mastectomy?

Journal of Clinical Anesthesiology

Steyaert A, Forget P, Dubois V, Lavandhomme P, De Kock M.

33:20-5

2015

PDF

Clinical evidence for dorsal root ganglion stimulation in the treatment of chronic neuropathic pain. A review.

Acta Anaesthesiologica Belgica

Forget P, Boyer T, Steyaert A, Masquelier E, Deumens R, Le Polain de Waroux B.

66(2):37-41

2013

PDF

Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial

Medical Hypotheses

Forget P, Berlière M, van Maanen A, Duhoux FP, Machiels JP, Coulie PG, Bouche G, De Kock M; Ketorolac in Breast Cancer trial -KBCtrial- group.

Ketorolac in Breast Cancer trial -KBCtrial- group. Med Hypotheses (2013); 81(4):707-12

bottom of page